Bone Marrow Pathology Predicts Mortality in Chronic Hemodialysis Patients

Table 4

Bone marrow biopsy findings stratified according to survival status ().

Variable	Total ()		Survivors ()	Nonsurvivors ()	value
Cellularity, (%)	Hypocellularity	40 (51.3)	20 (41.7)	20 (66.7)	0.077
	Normocellularity	23 (29.5)	18 (37.5)	5 (16.7)
	Hypercellularity	15 (19.2)	10 (20.8)	5 (16.7)
Megakaryocyte distribution, (%)	Normal	57 (73.1)	39 (81.3)	18 (60.0)	0.001^**
	Increased	6 (7.7)	6 (6.3)	0 (0)
	Decreased	13 (16.7)	3 (6.3)	10 (33.3)
	Absence	2 (2.6)	0 (0)	2 (6.7)
Morphology, megakaryocytes, (%)	Normal	77 (98.7)	48 (100.0)	29 (96.7)	0.385
	Dysplasia	1 (1.3)	0 (0)	1 (3.3)
M/E ratio	3.5 5.98		2.62 1.64	5.12 9.30	0.154
Myeloid series (%)	50.73 17.28		53.06 16.21	47.08 18.53	0.140
Blast cells (%)	0.90 1.06		1.02 1.19	0.70 0.77	0.213
Promyelocytes (%)	2.38 3.16		2.47 3.71	2.22 1.87	0.743
Myelocytes + metamyelocytes (%)	18.52 9.81		18.08 9.29	19.23 10.70	0.618
Band cell + segmental cell (%)	29.58 14.16		32.48 14.38	24.94 12.70	0.021^*
Morphology, myeloid series	Normal	77 (98.7)	48 (100.0)	29 (96.7)	0.194
	Abnormal	1 (1.3)	0 (0)	1 (3.3)
Erythroid series (%)	23.99 12.49		24.98 11.11	22.39 14.48	0.407
Morphology, erythroid series	Normal	77 (98.7)	48 (100.0)	29 (96.7)	0.328
	Dysplasia	1 (1.3)	0 (0)	1 (3.3)
Monohistiocytes (%)	1.07 1.23		1.10 1.32	1.02 1.14	0.814
Eosinophils (%)	3.41 3.23		3,91 3.19	2.60 3.19	0.085
Plasma cells (%)	4.40 10.25		2.64 2.24	7.35 16.28	0.139
Lymphoid cells (%)	15.59 11.56		12.99 7.77	19.74 15.10	0.029^*
Iron store (grade)	2.41 1.33		2.35 1.16	2.54 1.66	0.713

^*, ^**.